SI-BONE, Inc. (SIBN) stock
SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3048% above fair value
$23.73−0.02 (-0.08%)
Close on Nov 20, 2026Market cap $1.06BP/E –Yield 0.00%
Si-Bone shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Si-Bone's shares outstanding was 44M at Jun 30, 2026. For fiscal 2025 it was 43M, up 3.6% from the year before. The highest annual figure on record is 43M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 43M | +3.6% |
| FY2024 | Dec 31, 2024 | 41M | +7.9% |
| FY2023 | Dec 31, 2023 | 38M | +12.4% |
| FY2022 | Dec 31, 2022 | 34M | +3.2% |
| FY2021 | Dec 31, 2021 | 33M | +14.1% |
| FY2020 | Dec 31, 2020 | 29M | +17.6% |
| FY2019 | Dec 31, 2019 | 25M | +210.8% |
| FY2018 | Dec 31, 2018 | 8M | +129.3% |
| FY2017 | Dec 31, 2017 | 3M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 44M | +3.9% |
| Q1 FY2026 | Mar 31, 2026 | 44M | +3.8% |
| Q4 FY2025 | Dec 31, 2025 | 44M | +3.9% |
| Q3 FY2025 | Sep 30, 2025 | 43M | +3.5% |
| Q2 FY2025 | Jun 30, 2025 | 43M | +3.6% |
| Q1 FY2025 | Mar 31, 2025 | 42M | +3.4% |
| Q4 FY2024 | Dec 31, 2024 | 42M | +3.2% |
| Q3 FY2024 | Sep 30, 2024 | 42M | +3.6% |
| Q2 FY2024 | Jun 30, 2024 | 41M | +9.1% |
| Q1 FY2024 | Mar 31, 2024 | 41M | +17.2% |
| Q4 FY2023 | Dec 31, 2023 | 41M | +17.4% |
| Q3 FY2023 | Sep 30, 2023 | 40M | +17.2% |
| Q2 FY2023 | Jun 30, 2023 | 38M | +11.2% |
| Q1 FY2023 | Mar 31, 2023 | 35M | +3.3% |
| Q4 FY2022 | Dec 31, 2022 | 35M | +3.1% |
| Q3 FY2022 | Sep 30, 2022 | 34M | +3.0% |
| Q2 FY2022 | Jun 30, 2022 | 34M | +3.3% |
| Q1 FY2022 | Mar 31, 2022 | 34M | +3.4% |
| Q4 FY2021 | Dec 31, 2021 | 34M | +5.7% |
| Q3 FY2021 | Sep 30, 2021 | 33M | +16.1% |
| Q2 FY2021 | Jun 30, 2021 | 33M | +15.7% |
| Q1 FY2021 | Mar 31, 2021 | 33M | +20.0% |
| Q4 FY2020 | Dec 31, 2020 | 32M | +26.9% |
| Q3 FY2020 | Sep 30, 2020 | 29M | +15.8% |
| Q2 FY2020 | Jun 30, 2020 | 28M | +15.9% |
| Q1 FY2020 | Mar 31, 2020 | 27M | +11.7% |
| Q4 FY2019 | Dec 31, 2019 | 25M | +574.2% |
| Q3 FY2019 | Sep 30, 2019 | 25M | +587.4% |
| Q2 FY2019 | Jun 30, 2019 | 25M | +583.9% |
| Q1 FY2019 | Mar 31, 2019 | 24M | +593.4% |
| Q3 FY2018 | Sep 30, 2018 | 4M | +6.8% |
| Q2 FY2018 | Jun 30, 2018 | 4M | – |
| Q1 FY2018 | Mar 31, 2018 | 4M | – |
| Q4 FY2017 | Dec 31, 2017 | 4M | – |
| Q3 FY2017 | Sep 30, 2017 | 3M | – |
See a number that looks wrong?